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ABSTRACT
Many cancer cells over-express significantly the glycoproteins specific to the endogenous
cerebellar soluble lectin or CSL. These ligands may present the same electrophoretic profiles
regardless of the specie or tissue. We purified a large amount of the active CSL using an
immuno-affinity chromatography, which was used to isolate the CSL ligands from human
tumour K562 cell lines. After protease digestion of these ligands, we analyzed the obtained
peptides using reverse phase chromatography and isolated an overrepresented group that
carried N-glycans and was relatively hydrophobic. Thus, we suggested that the CSL ligands
have a common pepetide sequence specifically recognized by the CSL, who could direct the
production of these CSL-recognized N-glycans. Moreover, we speculated that the expression
deregulation of a specific exon encoding this peptide sequence alters the glycosylation in
K562 tumour cells.
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1. INTRODUCTION
The cell surface glycoconjugates, including glycoproteins, glycolipids and proteoglycans are
modified in the cancerous cells [1-6]. Nevertheless, the fonction of the glycosylation
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alterations in cancerogenesis is still incoherent, both inactivation and activation of
glycosyltransferases participate in cancer development process [7,8]. The abnormal
expression of oncogenes may control the biosynthesis of directly intervening glycosylation
enzymes, however, the exact mechanism of these enzymatic disturbances is still unknown
[7,9]. The promising assumptions suggesting the implication of the endogenous lectins in the
malignant process are suffering from the missing of obvious relation [10,11]. The biological
significance of these glycosylation aberrations in the cancerous cells is not clear; It can be
either a key event at the cancer origin or one of its multiple consequences. The
glycoconjugates influence the metastatic capacities of the cancerous cells and change
depending to the cell differentiation and the development stage [2,9,12,13]. The disturbance
of the glycobiologic interactions between the lectins and their ligands, including, the
membrane glycoproteins participates in the carcinogenesis process [10,14-17].
The endogenous cerebellar soluble lectin (CSL) was initially isolated from the rat cerebellum
[18,19]. It recognizes the glycoproteic glycans containing the oncofoetal epitopes [20-22].
The myelin-associated glycoprotein (MAG) and PO glycoprotein are CSL ligands [23-27].
The CSL ensures the molecules bridging between cellular surface glycoproteins during
various biological processes, such as the myelin compaction and the junctions construction
between axons and myelin producing cells [28-31]. The transformed cells possess a definitely
higher number of CSL ligands, compared to the normal cells [31,32]. The CSL ligands
overexpression generates a too great number of adhesion signals and contact inhibition loss,
which prevents the cellular answer (nonsense signal) [32]. However, the increase in the CSL
ligands levels does not stimulate the major glycoproteins expression; there is no modification
on the total glycans biosynthesis. Furthermore, there is a practically perfect similarity between
the CSL ligands profiles in various cell lines or malignant tumours, whatever is the tissue
origin or the specie, suggesting that the CSL ligands had a specific profile in cancer [32]. The
principal objective of this work was to seek if the CSL ligands specifically overexpressed in
the tumour cells presente a consensus peptide, a sequence signal for the CSL-recognized
glycans biosynthesis. We first prepared the CSL ligands-enriched material from the human
K562 tumour cells. Then, we isolated the CSL ligands by affinity chromatography on
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CSL-immobilized column and tried to establish their peptide maps using protease digestion
and reverse phase chromatography.
2. EXPERIMENTAL
2.1. Chemicals, tissues and cell lines
Avidin-labeled alkaline phosphatase (avidin-AKP), bovine serum albumin (BSA), trypsin,
protease V8, nitrotetrazolium blue, 5-bromo-4-chloro-indolyl phosphate, p-tosylarginine
methylester (TAME), phenylmethylsufondyle fluoride (PMSF) and the culture medium
RPMI61640 were purshed from Sigma (St Louis, MO, the USA). The N-hydroxy-succinimide
ester biotin (NHS-Biotin) was from Bio-Rad (Ivry sur Seine, France). The sodium dodecyl
sulfate (SDS) and the acrylamide were from Appligen (Strasbourg, France). The nitrocellulose
filters (0.22 µm) was from Schleicher and Schuell (Dassel, Germany). The cyanogen bromide
(CNBr)-activated Sepharose 4B was from Pharmacia (Upsala, Sweden). The Vytrac C18
HPLC column was from Interchim (Montlucon, France). The acetonitrile and trifluoracteic
acid were from Merck (Darmstadt, Germany). Wistar albinos little rats (18-days old) were
used in our study. The females in gestation were isolated just before the low setting and
regularly supervised. The K562 tumour cells derived from human erythrocyte leukemia
(K562 cells) were from the Center of Cancerlogy (Fondation Bergonié, Bordeaux, France).
2.2. SDS-page and western blot analysis
Prior to electrophoresis, the proteins were pulled down with 10% trichloroacetic acid (TCA)
or methanol at pH 5. After centrifugation (3.400 g for 30 min), the pellet was rinsed with
methanol and solubilized in 1% SDS and the proteins concentrations were determined [33].
Then, the pellets were solubilized in the dissociation solution (62 mM Tris-HCl pH 6.8, 2%
SDS, 10% glycerol, 5% lhjkj, 1% bromophenol blue) as recommended by Laemmli and
heated at 90°C for 5 min [34]. The total proteins (20 µg/well) were separated by SDS-PAGE
(13%) and colored by immersion in 1% Coomassie Blue Brilliant R (CBB) [35].
After electrophoresis, the proteins were bloted on nitrocellulose filters in buffer (12.5 mM
Tris-HCl, 96 mM glycine containing 20% methanol and 0.04% SDS) under 36 V and 400 mA
[36]. To check the quality of the electrophoretic migration and the effectiveness of the transfer,
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a short coloring of the blots with the red culvert (0.2% red culvert in 3% TCA) was done. The
filters were cleaned three times with water and then incubated with 3% BSA in PBS (25 mM
sodium phosphate pH 7.2 containing 150 mM NaCl) during 1 h at room temperature. The
biotinylated CSL (Bio-CSL) was added at a final concentration of approximately 0.16 µg/ml
and let to incubate during 4 h at room temperature. Then, the blots were washed with PBS
during 1 h for ten times. After the second incubation with 3% BSA for 30 min, a new washing
step with PBS was done for 1 h. Then, the blots were incubated with the BSA for 30 min,
supplemented with the Avidin-AKP and let at 4°C (2 h). Finally, the blots were rinsed with
PBS (1 h), with PBS containing 0.1% Triton X-100 for two times and with water for three
times. The fixed avidin-AKP was revealed by the nitrotetrazolum blue and the
5-bromo-chloro-3-indolylphosphate [37].
2.3. Proteins extraction and immunoaffinity chromatography
Rat cerebella (3 g) were traited with a series of sequential extractions by homogenisation
followed by successive centrifugations in different buffers containing 0.1 mM PMSF and 0.26
mM TAME [19].  The extractions were executed at 4°C as below: 300 ml buffer T (10 mM
Tris-HCl pH 7.2: Fraction T); 150 ml buffer TN (buffer T containing 0.4 M NaCl: Fraction
TN1); 100 ml buffer TN (Fraction TN2); 100 ml buffer TNM (buffer TN containing 0.5 M
Mannose: Fraction TNM). The pellet coming from each extract was initially homogenized in
water, to which the buffer T was added (90%). After centrifugation, the supernatant (20 ml)
was pulled down with 10% TCA and the precipitated proteins were quantified [33] and
analyzed by SDS-PAGE.
The extract TNM, a CSL enriched fraction was supplemented with 0.1 mM PMSF and 0.26
mM TAME, diluted four times with the buffer T and passed through an anti-CSL Sepharose
4B column, previously equilibrated with the buffer TNM. Then, the column was subjected to
a series of successive washings in the following buffers: 15 ml buffer TN1/4 (10 mM
Tris-HCl pH 7.2, 0.1 M NaCl); 15 ml buffer TNM1/4 (buffer TN1/4 containing 0.5 M
Mannose); 15 ml buffer TN1/4; 15 ml buffer PBS1/2 (2.5 mM sodium phosphate pH 7.2, 75
mM NaCl). The lectin elution was initially carried out by increasing the ionic force with
buffer PBSX3 (75 mM sodium phosphate pH 7.2 and 450 mM NaCl), and then by pH
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reduction with 0.2 M glycine-HCl pH 2. Aliquots corresponding to the various peaks were
taken in order to quantify the total proteins, check the purity and the integrity of the lectin by
SDS-PAGE and test their activity [33, 38].
2.4. CSL activity measurement
We evaluated the CSL activity by testing its capability to fix cell surface glycans of rat
erythrocytes (agglutination test). The animal blood was recuperated in the 50 mM citrate
buffer pH 7.2 and centrifuged (1800 g for 10 min). The pellets were traited with 1%
glutaraldehyde in PBS and washed ten times with PBS. A series of dilutions of the purified
lectin were been done in concave-bottomed wells. After addition of 100 µl of blood red cells,
the plates were left at room temperature for 2 h.
2.5. Proteins biotinylation
After an exhaustive dialysis against PBS, the CSL was keept at pH 9 until use. Six hundreds
µg of CSL were added to 10 µl of NHS-Biotin and let to react at 4°C for 1 h, under
intermittent agitation. After blocking of the reagent excess by 100 µl of 0.2 M glycine in 0.2
M dipotassic phosphate, the Triton X-100 was added at a final concentration of 0.1%. The
biotinylated CSL (Bio-CSL) was purified by exclusion chromatography (Ultrogel AcA 202
column) using PBS containing 0.1% Triton X-100. To check the Bio-CSL quality, three types
of tests were corried out.  Firstly, ELISA micro-titration plates were impregnated with
Bio-CSL, dried at 37°C, saturated with BSA, washed several times and supplemented with
Avidin-APK. The fixed Bio-CSL was detected by addition of p-nitophenylphosphate and
absorption measurement at 405 nm.  Secondly, the lectin integrity was estimated by
SDS-PAGE and revelation with CBB or silver nitrate. Finally, the Bio-CSL activity was
evaluated using the agglutination test.
2.6. Cells culture and proteins extraction
The K562 cells were cultivated in RPMI-1640 medium containing 10% SVF, to which we
added penicillin (100 U/ml) and streptomycin (1mg/ml). The cells were kept at 37°C in an air
atmosphere containing 5% CO2 and the culture medium was changed twice per week. The
confluent K562 cells (4.68 g) were washed three times and subjected to a series of sequential
extractions [19].  The following buffers were successively used: 300 ml buffer T (10 mM
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Tris-HCl, pH 7.2); 150 ml buffer TN (buffer T containing 0.4 M  NaCl) (Fraction TN1); 100
ml buffer TN (Fraction TN2); 100 ml buffer TNM (buffer TN containing 0.5 M Mannose);
100 ml buffer TNTM (buffer TNM containing 0.5% Triton X-100); 50 ml water. All steps
were performed under conditions identical to those described for the extraction of cerebellum
proteins. The proteins were quantified [33] and analyzed by SDS-PAGE.
2.7. Affinity chromatography
The purified CSL (4 mg) was immobilized on CNBr-activated Sepahrose 4B (1.25 g). The gel
was extensively rinsed with 500 ml 1 mM HCl on sintered glass and then supplemented with
the CSL preparation. The mixture thus obtained was kept at 4°C under slow agitation for one
night and the remainder of the gel active sites was blocked by adding 1 ml 1 M ethanolamine.
The crude proteins extracts (TN, TNM) from the K562  cells were diluted four times in
buffer T, complemented with 0.26 mM TAME and 0.1 mM PMSF, and passed through the
CSL-immobilized column previously equilibrated  in buffer TN1/4 (20 ml/h). After washing
with the buffer TN1/4, the retained material was eluted with 40 ml buffer TN, 30 ml buffer
TN and 15 ml water. An aliquot of each peak (1/10) was pulled down with 10% TCA and used
for the proteins quantification and SDS-PAGE analysis.
2.8. Proteolytic hydrolysis and reverse phase chromatography
The CSL ligands preparation was pulled down with 10% TCA and suspended in 0.01% SDS.
The obtained proteins (50 µg ) were treated separately either by  trypsin (1µg in  25 mM
Tris-HCl  pH 7.7 at 37°C) or by proteinase V8 (1µg in 50 mM ammonium carbonate pH 4 at
room temperature). The reactions were blocked by proteins denaturation in acidic medium.
The obtained peptides were separated using the reverse phase chromatography in which the
stationary phase consisted of silica particles coated with a covalently bounded 18-atoms
hydrocarbon chains (diameter of 5 µm), while a water/acetonitrile mixture represented the
mobile phase. After the column equilibration (250×4.6 mm, 300 A°) with 0.1%
trifluoro-acetic acid (TFA) in water, the sample was injected using a micro-syringe. The
elution was done by acetonitrile increasing gradient (1 ml/min) and detected by absorption at
205 or 226 nm.
2.9. Revelation of glycans-contained peptides
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The peptides fractions separated by reverse phase chromatography were lyophilized in a
vacuum centrifuge, the pellets thus obtained were included in 20 µl H2O and aliquots (1 µl)
were deposited onto a nitrocellulose filters as a dot. The glycosylated peptides were revealed
by addition of Bio-CSL and Avidin-AKP.
3. RESULTS AND DISCUSSION
3.1. Active csl purification
The purification of the active CSL represents an important step of the CSL ligands isolation.
The obtaining of relatively large amount of CSL is necessary for the preparation of the
CSL-based affinity column, allowing isolating the CSL ligands. In fact, we isolated three
isoforms of CSL from the cerebella of young rats; their respective molecular weights were
31.5 kDa, 33 kDa and 45 kDa [19]. These soluble and polyvalent lectins possess a very high
specificity for hybrid glycans, whose precise structure is not yet completely known. The
dissociation constant of these endogenous glycans has been estimated at least at 10-8 M [38].
We purified the CSL on two essential steps: a specific solubilization by mannose and an
immunoaffinity chromatography [19]. Given that the rat cerebella are rich in membranous
CSL ligands between the 14th and the 18th days of the postnatal life, we used the18-days old
rats in our study. During the homogenization of the tissues in non-denaturing conditions, the
main part of the CSL was bound to its insoluble glycoprotein ligands, while most of the
soluble proteins were excluded [19]. Therefore, we supplemented the extraction buffers with
mannose in order to specifically solubilize the CSL by detaching it from its endogenous
ligands.
Our results indicated that the characteristic doublet of CSL (MW: 31.5 kDa and 33 kDa) was
detected only during the proteins extraction by mannose solubilization (Fig. 1, wells f and g).
At this purification step, the 45 kDa subunit was still undetectable; it was present in very
small quantities and strongly contaminated with proteins of similar molecular weight. The
lectins solubilization by mannose resulted in a great CSL enrichment. However, It also
allowed the solubilizing of a large number of proteases, which can limit the lifetime of the
immuno-affinity columns.
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We chose the immunoaffinity chromatography to purify the CSL, it is the best-adapted
technique for the proteins purification [39,40]. Indeed, we have isolated two CSL subunits
(31.5 kDa and 33 kDa) in a pure state and under relatively mild elution conditions (Fig. 2,
well e). The 45 kDa subunit appears to be more strongly retained, because it was only
eliminated from the column by acidic elution (200 mM glycine-HCl pH 2.5) flowed by
washing with PBSX3 (Fig. 2, well g).
Fig.1. SDS-PAGE profiles of total proteins from rat cerebellum extracts. 15 μg of total
proteins are used in each well, electophoretically analyzed and CBB stained. a) Molecular
weight marker (kDa); b) fraction T; c) fraction TN1; d) fractions TN2; f) and g) fractions
TNM. The arrows indicate the CSL subunits (33 and 31.5 kDa)
Therefore, we suggested that the 45 kDa CSL subunit was precipitated at this acidic pH and
re-solubilized when the pH gone up [41]. The differential elution of the various CSL subunits
means that each subunit may constitute a specific homo-polymer. The CSL, a polyvalent
molecule, is an agglutinin, capable to bind rat erythrocytes. Our CSL preparations have
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showed a more or less levels of activities, but there was a constant relationship between the
proteins quantity and their agglutinant capacity (Fig. 3). The agglutination activity was
detectable at a starting concentration of 0.5 µg/ml of purified lectin.
Fig. 2. SDS-PAGE control of the CSL preparation obtained by immunoaffinity
chromatography. a) Molecular weights marker (kDa); b) material deposited on the column
(fraction TNM); c) flow through; d) washing with TN; e) and f) successive fractions eluted
with PBSX3; g) elution with glycine-HCl. The arrows indicate the CSL subunits (33 and 31.5
kDa)
Fig. 3. Measurement of the CSL activity by the agglutination tests. Successive dilutions (1-10)
of the purified CSL from different preparations (A-D) were prepared and added to ELISA
wells containing erythrocytes. The well E1corresponds to PBS instead of the lectin. The
arrows indicate the maximum of the CSL dilution, which cause the agglutination
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3.2. Isolation of the csl ligands
We used the CSL-immobilized Sepharose 4B gel to purify the CSL ligands from the Fraction
TN1, which is detergent free and relatively rich on the CSL ligands. The absence of the Triton
X-100, a non-ionic detergent helped us in fallowing the proteins sorting from the column.
After a slow adsorption of the material on the affinity column, we extensively washed the
column with buffer TN and buffer TN/4. The elution of the CSL ligands was done using four
successive solutions: TN, TNM, water and ammonium formiate. The buffers sequence
(TN/4-TN-TNM) was useful to take down specifically the CSL ligands. The water rinsing
leads us to decrease the effect of the buffer TNM. In order to elute the very strongly fixed
CSL ligands, we used the ammonium formiate at low pH, which was eliminated by prolonged
lyophilization. As many cancerous cells, the K562 cells are very rich in CSL ligands [32]. We
observed varying profiles of CSL ligands form one fraction to another when the CSL ligands
expression in the different fractions from the sequential proteins extraction of K562 cells was
analyzed by Western blotting using the Bio-CSL and Avidin-AKP and (Fig. 4). While a very
small part of these ligands was solubilized in the buffer T under a weak ionic force (Fig. 4: b),
a larger one was present in the fractions with a strong ionic force and without detergents (Fig.
4: c, d and e). By contrast, a considerable quantity of CSL ligands was recovered by strong
ionic force and detergent (Fig. 4: f).
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Fig. 4. Electrophoretic control of the proteins contained in the K562 cells extracts. A:
SDS-PAGE (CBB Staining); B: Western blot (CSL ligands revealed with Bio-CSL and
avidin-AKP). a) Molecular weights marker (kDa); b) fraction T; c) fraction TN1; d) fraction
TN2; e) fraction TNM; f) H2O
These membranous CSL ligands were completely different from the soluble ones; they
showed low molecular weights and specific electrophoretic profiles. These results agree with
the data observed in CHO cells [30], suggesting that the soluble CSL ligands did not derive
from the membranous ligands by a proteolysis, since they had a higher Molecular weights.
Moreover, we suggested that the soluble ligands participate in the extracellular matrix
formation and stamps where the CSL could be a bridging molecule as it was shown in the
CHO cells [30]. The comparison between the SDS-PAGE (silver nitrate colouring) of total
proteins and the western blotting (Bio-CSL and Avidin-AKP revelation) of CSL ligands
showed an extremely similar profiles (Fig. 5 A and B). This observation indicated that the
CSL ligands were predominant in the initial material. Thus, the CSL affinity chromatography
was very efficient in CSL ligands specific isolation. However, compared to the total proteins
present in Fraction TN1, the ligands amounts were minor components. Previous works have
showed a strong over-expression of the CSL ligands in the tumour cells compared to the
A           B
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normal cells [31,32].
Fig. 5. Electrophoretic control of the CSL ligands isolated by CSL-affinity chromatography. A:
SDS-PAGE (silver staining); B: Western blot (CSL ligands revealed with Bio-CSL and
avidin-AKP). a) molecular weights marker (kDa); b) non-retained fraction; c) elution with
TN/4; d) elution with TN; e)elution with TNM
3.3. Seeking for a sequence common to the csl ligands
The CSL ligands may possess a consensus sequence which acts as a peptide signal for their
own glycans biosynthesis. Therefore, we tried to identify a group of over-represented peptides
by CSL ligands digestion using suitably chosen proteases. It is difficult to know if the CSL
ligands are present or not in the normal cells, however, only a few number of them were
implicated in the adhesion process. This may implies the expression regulation of exons
encoding these sequences, which was altered in the tumour cells and could be responsible of
over-producing the CSL glycoprotein ligands [42,43]. The chromatograms of the CSL ligands
digestion with protease V8 or trypsin showed two major peaks, beside a various minor peaks
(data not shown). This result was expected regardless the initial assumption. Using the
Bio-CSL test, We clearly demonstrated that those major peaks were CSL-recognized
glycopeptides (Fig. 6). These results agree with a previous study who reports that the two
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isoforms of the myelin-associated glycoprotein (MAG) are CSL ligands [44].
Fig. 6. Revelation of the CSL-recognized peptides by dot blot. The spots A (1-10) are the
peptide fractions 1-10; the spots B (1-10) are the peptide fractions 11-20; the spots C5and C6
correspond to 1 and 0.5μg of MAG not recognized by the CSL; the spots C7 and C8
correspond to 1 and 0.5μg of MAG recognized by CSL; the spots C9 and C10 correspond to 1
and 0.5 ug of bovine serum albumin. The spots B2 and B3 (strongly revealed) correspond to
the major peaks observed in reverse phase chromatography
Moreover, the hydrophobic character of these glycopeptides indicates that the polypeptide
chains were mainly responsible of the separation of the protease digestion products. Therefore,
we expected that this common peptide sequence if exist should be hydrophobic and closed to
the N-glycosylation sites of the CSL-recognized ligands. The isolation of a large quantity of
these glyco-peptides should allow us to study their sequences and check our initial
assumption about the existence of a peptide signal necessary to the CSL-recognized glycans
biosynthesis. The N-glycans biosynthesis is directed by the presence of the sequence:
Asn-X-(Ser/thr), however, the precise regulation process implicated in the N-glycosylation is
still unknown [45,46]. It has been suggested that the N-glycosylation concerns only the
accessible asparagine. The alternative splicing is implicated in the expression of a
well-studied proteins family, the Cell Adhesion Molecules [47]. The diversity of the
polypeptide chains could be a key to explain the differences of the glycosylation profiles of
the CSL ligands in human K562 tumour cells [42].
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4. CONCLUSION
We identified a glycoproteins family that specifically recognize the CSL in human tumour
cells. Indeed, we showed an over-represented peptides group, which probably come from all
CSL-recognized glycoproteins. Our results suggest that the glycoprotein ligands of the CSL
share a common sequence near the N-glycosylation site. This sequence may be a peptide
signal directing the biosynthesis of the CSL-recognized glycans in tumour cells and could
originate from a translation deregulation of a particular exon encoding this sequence.
However, given that the glycans part is not negligible, we cannot definitely confirm the
existence of this peptide sequence common to these glycoproteins. The knowledge of this
signal sequence may allow us to understand the malignant process of carcinogenesis. Indeed,
obtaining antibody against this sequence would lead to identify and insolate glycoproteins
containing CSL-recognized glycans. Moreover, we can prepare specific oligonucleotides to
screen and analyse expression of these sequences.
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